Hutch News
Results per Page:
Landmark scientific paper turns 40
First unequivocal proof in humans of immune cells’ cancer-curing power laid the groundwork for cancer immunotherapy, modern bone marrow transplantation
Radiation dose and cancer risk after bone marrow transplant
High-dose radiation, younger age increase risk of developing subsequent cancer, new study finds
A boy, his chicken and a bone marrow transplant
An experimental treatment — and an unconventional pet — offered both hope and healing for Andrew Adams’ rare and debilitating genetic disorder
Three's a charm in a triple-drug combination for transplant patients
A drug with a storied past offers a new edge against an old foe
Good News at Fred Hutch: Immunotherapy pioneer named chair, Nobel laureate keynotes
Celebrating faculty and staff achievements
From building toys to developing cures
At 80, transplant scientist Dr. Rainer Storb can't stop tinkering with — and solving — medical puzzles
Life with graft-vs.-host disease: When the transplant is just the beginning
How researchers are trying to combat this common, often debilitating side effect of treatment
Gentler treatment for many with graft-vs.-host disease
A new study finds halving standard steroid dose treats most acute GVHD just as well; could limit dangerous side effects
Age alone no longer barrier to stem cell transplants for older patients
Mohamed Sorror-led study shows years play little role in patient outcomes following Center-developed 'mini-transplant'
Science Backgrounder: Nothing Small About "Mini-Transplants"
Developed at the Hutchinson Center, therapy uses minimal doses of radiation
Tag, You Are It: A Two-Step Approach to Treating Patients with Multiple Myeloma Shows Promise
Fred Hutchinson Cancer Research Center Investigator Presents Preliminary Study Results at the American Society of Hematology Meeting in Orlando, Fla
"Mini-Transplantation" Offers Alternative and Hope for Older Patients, and Patients with Limited Treatment Options
Procedure appears to offer easier, better, lower-cost therapy for a wide range of patients with leukemia, myeloma, lymphoma, and other diseases